The Street



The Street Recent News

'Riding So More Jimmy's Can Ring The Bell': TheStreet's Adam Feuerstein To Bike For Jimmy Fund, Dana-Farber Cancer Institute
The Bull-Bear Debate In Therapeutics Rages From Research Notes To Twitter
Feuerstein Throws BioMarin Into Gilead Takeover Speculation
Amgen's Repatha Results Not Good Enough For The Street
Price Action Comparisons Notwithstanding, Mario Could Be Nintendo's Financial Boon In A Way 'Pokémon GO' Never Was
Chipotle Exec: We're Not Recovering Like We Hoped
Foot Locker Should Benefit From Favorable Industry Tailwinds
The Startup That Wants To Bring Expert Networks To Every Investor
Brian Sozzi Agrees With Jefferies' Downgrade Of Best Buy
Jim Cramer Smells Success At International Flowers & Fragrances
Citron's Andrew Left: Valeant Was Able To 'Game The System,' Now It's 'A Sinking Ship'
Sozzi: Auntie Anne's Business Is Doing Just Fine
Opinion: Twitter Has Been 'Trending Lately,' But That's 'Not All Good News'
Citigroup CEO Estimates 25% Drop In Q2 Profits
Adam Feuerstein On Biotechs: 'I Have An Itchy Trigger Finger On Hypocrisy'
Chiasma Plunges 14%; Feuerstein Source Says FDA Will Reject Co.'s Therapy Capsules
Clovis Oncology Falls 8%: Here's What You Need To Know
Pacific Sunwear Killed By Bloomberg Bankruptcy Prep Report
Jabil's Guidance Is Bad Sign For Apple's iPhone
Sarepta Therapeutics Gives Up Gains Following Notable Tweet
Will Apple Be Netflix's Next Contender? New Reports Suggest Apple's Training For The Arena
Adam Feurestein Reminds Twitter Followers 'Today Is Merck's HepC elbasvir/grazoprevir PDUFA'
Following Goldman Sachs' Downgrade, Caterpillar Drops 4.3%